Clinical Trial Update: A Study to Learn About How a New Pneumococcal Vaccine Works in Adults [Phase 1]

View source ↗

Summary

Pfizer is conducting a Phase 1 clinical trial to study how a new pneumococcal vaccine behaves in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Pfizer pneumococcal vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Streptococcus Pneumoniae | Phase 1 | Status: ACTIVE_NOT_RECRUITING